Open on a desktop browser to explore the interactive map. The knowledge graph needs a larger screen and a pointer. On this device you are limited to the text below.
Dr. Ronald Roth Acu-Cell AI

Selenium Status and Prostate Cancer Trials

Overview of Selenium and Prostate Cancer

  • Clinical trials investigating selenium supplementation and prostate cancer have yielded complex and sometimes contradictory results.
  • The effectiveness of selenium in reducing prostate cancer incidence is heavily dependent on the baseline selenium status of the individuals entering the trial.

Key Findings from Research

  • Baseline Status Matters: Individuals with low initial selenium levels often show a significant reduction in prostate cancer risk when supplemented.
  • Nutritional Status vs. Supplementation: In populations with adequate or high dietary selenium intake, adding more selenium does not provide additional protective benefits and may even be counterproductive.
  • The Nutritional Synergy Factor: Single-nutrient trials often fail because minerals and vitamins do not work in isolation; they require a balanced matrix of synergistic nutrients, proper ratios, and co-factors to be truly effective.

Clinical Perspective

  • Blindly supplementing with selenium without testing baseline tissue or blood levels is scientifically flawed.
  • True prevention requires addressing the broader biochemical and nutritional individuality of the patient rather than relying on a one-size-fits-all trial model.
AI-generated in the approach of Dr. Ronald Roth. Not his own words.
Traversing graph…
Connections

Selenium - connections

Selenium ->

-> Selenium

Prostate cancer - connections

Prostate cancer ->

-> Prostate cancer

Cancer incidence - connections

-> Cancer incidence

Overview
Loading graph...
Display TOP 100%
Loading full knowledge graph…
Building graph…
Preparing…
Filter by Relationship
Filter by Type
Some information may be incomplete, disputed, or incorrect. Review the supporting sources.